Efficacy of antifibrotic treatment for ANCA-positive fibrosing interstitial lung disease: a retrospective case‒control study
Add-on antifibrotic medications seem to effectively slow the deterioration of lung function in patients with ANCA<sup>+</sup> fILD without causing any obvious new-onset adverse reactions.
Authors
- Q P Liu (ORCID: https://orcid.org/0000-0002-5304-3173)
- Zhiyi Li (ORCID: https://orcid.org/0000-0002-2491-518X)
- Zuojun Xu
- Ruxuan Chen
- Hui Huang
- Chi Shao
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1186/s12890-026-04109-1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00